Cargando…
Large Variations in the Prices of Urologic Procedures at Academic Medical Centers 1 Year After Implementation of the Price Transparency Final Rule
IMPORTANCE: Patients with urologic diseases often experience financial toxicity, defined as high levels of financial burden and concern, after receiving care. The Price Transparency Final Rule, which requires hospitals to disclose both the commercial and cash prices for at least 300 services, was im...
Autores principales: | Gul, Zeynep G., Sharbaugh, Danielle R., Guercio, Cailey J., Pelzman, Daniel L., Jones, Cameron A., Hacker, Emily C., Anyaeche, Vivian I., Bowers, Levi, Shah, Ashti M., Stencel, Michael G., Yabes, Jonathan G., Jacobs, Bruce L., Davies, Benjamin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857154/ https://www.ncbi.nlm.nih.gov/pubmed/36602800 http://dx.doi.org/10.1001/jamanetworkopen.2022.49581 |
Ejemplares similares
-
Mohs Surgery Price Transparency and Variability at Academic Hospitals After the Implementation of the Federal Price Transparency Final Rule
por: Jain, Neelesh P, et al.
Publicado: (2023) -
Factors Associated with Compliance to the Hospital Price Transparency Final Rule: a National Landscape Study
por: Jiang, John Xuefeng, et al.
Publicado: (2021) -
Enhancing medicine price transparency through price information mechanisms
por: Hinsch, Michael, et al.
Publicado: (2014) -
Provision of Hospital Price Information After Increases in Financial Penalties for Failure to Comply With a US Federal Hospital Price Transparency Rule
por: Kong, Edward, et al.
Publicado: (2023) -
Are payors ready for transparent prices yet?
por: Barman-Aksözen, Jasmin
Publicado: (2022)